Skip to content

Pharmaceutical Development Group (PDG) is a subsidiary of Biotech Research Group Corporation.

+1.813.333.2950 info@pharmdevgroup.com
Facebook page opens in new windowTwitter page opens in new windowDribbble page opens in new window
PDG
Pharmaceutical Development Group
PDGPDG
  • Home
  • Services
    • Pharmaceutical Consulting Services
    • Strategic Drug Development
      • Strategic Drug Development Services
      • Pharmaceutical Development Programs: Implementation and Oversight
      • Pre-IND Meetings
      • Investigational New Drug Application (IND)/Special Protocol Assessment (SPA)
      • Clinical Trial Design
      • Pre-NDA Meetings and NDA Submissions: 505(b)(1)/505(b)(2)
      • 505(b)(2) NDAs
      • Generic Drugs: 505(j) ANDAs and Potential Diversification
      • Nonprescription Drugs (OTC)
    • Medical Device Consulting
      • Exempt Devices / 513(g) Submissions
      • Device Pre-submission Meetings and Reviews
      • Facility Inspection Readiness
      • Combination Device and Drug/Biologic Submissions
      • 510(k) Submissions
      • PMA Submissions
    • Post-Launch Activities
      • Drug Post-Launch Activities
      • Post-Marketing Surveillance
      • Drug Labeling
    • Specialty Services
      • Specialty Services
      • Citizen Petitions
      • Legal Support
      • Literature Searches
      • Pharmacokinetic Consulting
      • Quality Assurance & Compliance
      • Scientific and Technical Writing
      • Supplier/Vendor Selection and Qualification
      • Toxicology Consulting
  • Regulatory Updates
  • About PDG
    • About PDG – An FDA Regulatory Consultant
    • Your Pharmaceutical Consultant
    • Careers at PDG
  • Regulatory Resources
    • Regulatory Resources
    • FDA Links
    • International Health Authority’s Websites
  • Contact PDG
  • Home
  • Services
    • Pharmaceutical Consulting Services
    • Strategic Drug Development
      • Strategic Drug Development Services
      • Pharmaceutical Development Programs: Implementation and Oversight
      • Pre-IND Meetings
      • Investigational New Drug Application (IND)/Special Protocol Assessment (SPA)
      • Clinical Trial Design
      • Pre-NDA Meetings and NDA Submissions: 505(b)(1)/505(b)(2)
      • 505(b)(2) NDAs
      • Generic Drugs: 505(j) ANDAs and Potential Diversification
      • Nonprescription Drugs (OTC)
    • Medical Device Consulting
      • Exempt Devices / 513(g) Submissions
      • Device Pre-submission Meetings and Reviews
      • Facility Inspection Readiness
      • Combination Device and Drug/Biologic Submissions
      • 510(k) Submissions
      • PMA Submissions
    • Post-Launch Activities
      • Drug Post-Launch Activities
      • Post-Marketing Surveillance
      • Drug Labeling
    • Specialty Services
      • Specialty Services
      • Citizen Petitions
      • Legal Support
      • Literature Searches
      • Pharmacokinetic Consulting
      • Quality Assurance & Compliance
      • Scientific and Technical Writing
      • Supplier/Vendor Selection and Qualification
      • Toxicology Consulting
  • Regulatory Updates
  • About PDG
    • About PDG – An FDA Regulatory Consultant
    • Your Pharmaceutical Consultant
    • Careers at PDG
  • Regulatory Resources
    • Regulatory Resources
    • FDA Links
    • International Health Authority’s Websites
  • Contact PDG

Blog

You are here:
  1. Home
Toxicology Consulting

Toxicology NDA Consulting

Services, Specialty ServicesBy PDG Regulatory ExpertApril 11, 2014

PDG Provides Strategic Toxicology Consulting from Development through NDA Submission In terms of strategy, one of PDG’s most critical functions is attempting to reduce toxicology study requirements. For example, in a recent meeting with FDA, we presented data in support of waiving the carcinogenicity requirements for a new drug product. Our presentation consisted of an…

Details
←1
2345678910111213141516171819202122
…2324252627←
By Keyword
505B2 510K ANDA biologics biologics-device cbe changes being effected Citizen Petition Clinical Trial Design combination products drug-device drug development Drug Development Services FDA Compliance FDA Consultants FDA Consulting FDA Regulations FDA Regulatory Affairs FDA regulatory consultants Florida RAPS generic Generic Drug Labeling Generic Drug Submissions Labeling Compliance medical device NDA NDA Consultants NDA Deviation OTC OTC Monograph Pharmaceutical Consultants Pharmaceutical Consulting Pharmaceutical Legislation pharmaceutical product development Pharmacovigilance Prescription Drugs RAPS Regulatory affairs services Regulatory consultant regulatory path Rx to OTC safety surveillance TFM Unapproved Drugs User Fees
Fill Your Details Here.







    Pharmaceutical Development Group

    PDG® is a federally registered service mark of Pharmaceutical Development Group, Inc.Pharmaceutical Development Group (PDG) is a subsidiary of Biotech Research Group Corporation.

    Service
    • Strategic Drug Development
    • Medical Device Consulting
    • Post-Launch Activities
    • Specialty Services
    Regulatory Updates
    • Labeling / Marketing
    • Medical Device Consulting News
    • Pharmaceutical Consulting News
    • Quality Assurance & Compliance
    • Regulatory Affairs
    • Research & Development
    • Safety & Pharmacovigilance
    • Submissions
    Regulatory Resources
    • Regulatory Resources
    • FDA Links
    • International Health Authority’s Websites
    • About PDG
    • Contact
    • Privacy
    • Terms of Use
    • Careers at PDG
    • Blog
    • Site Map
    Footer Menu
    Go to Top